Shannon Ferrante, n/a

Kyowa Kirin Inc
Princeton, New Jersey, United States

Disclosure information not submitted.

Presentation(s):

• SAT-742 - Real-world biochemical effectiveness in patients with XLH treated with burosumab or phosphate and vitamin D

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT